Figure 3.
TRIM21 mediates Lys63-linked ubiquitination around type II Toxoplasma. (a) Representative immunofluorescence confocal images of IFNγ-stimulated wild-type (upper panel) or TRIM21 knockout (lower panel) mouse embryonic fibroblasts infected 1 h with type II Toxoplasma expressing GFP and stained for Lys48 ubiquitin (left panel) or Lys63 ubiquitin (right panel). Scale bar is 5 μm. (b) Quantification of ubiquitin- (Ub), Lys48 ubiquitin- and Lys63 ubiquitin-positive parasite-containing vacuoles in IFNγ-stimulated wild-type versus TRIM21 knockout MEFs infected 1 h with type II Toxoplasma. Data were pooled from three independent experiments. Mean ± SEM, *p < 0.05, **p < 0.005, 2-way ANOVA. (c) Quantification of Lys63 ubiquitin-positive parasite-containing vacuoles in IFNγ-stimulated mouse embryonic fibroblasts infected 1 h with the canonical Toxoplasma type III (CEP) strain and Toxoplasma type III strain transgenic for the type I version of Rop18 (CEP Rop18I). Mean ± SEM, **p < 0.005, 2-way ANOVA. (d) Quantification of GBP1 and GBP2 localisation to the parasite-containing vacuoles in IFNγ-stimulated wild-type versus TRIM21 knockout mouse embryonic fibroblasts 1 h p.i. Data pooled from three independent experiments, unpaired t-test.